It recorded a net loss of $2.9 million. Diluted earnings per share were -$0.01.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2017
Dec 31, 2017
|
FY 2016
Dec 31, 2016
|
FY 2015
Dec 31, 2015
|
FY 2014
Dec 31, 2014
|
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
|
—
|
—
|
—
|
—
|
0
|
—
|
—
|
—
|
| Gross profit |
—
|
—
|
—
|
—
|
—
|
—
|
0
|
—
|
—
|
—
|
| Research and development |
2
-1.0%
|
2
+25.9%
|
2
-21.3%
|
2
+113.0%
|
1
+44.6%
|
1
|
1
|
—
|
—
|
—
|
| Selling, general and administrative |
1
-18.3%
|
2
+28.8%
|
1
-13.1%
|
2
+49.0%
|
1
-15.7%
|
1
|
4
+19.7%
|
4
-32.5%
|
5
-31.8%
|
8
+254.5%
|
| Operating income |
-4
+8.4%
|
-4
-27.1%
|
-3
+18.9%
|
-4
-81.1%
|
-2
-9.1%
|
-2
|
-5
-14.3%
|
-4
+19.3%
|
-5
+31.8%
|
-8
-254.5%
|
| Net income |
-3
-102.6%
|
-1
+53.6%
|
-3
+22.9%
|
-4
-85.1%
|
-2
+1.9%
|
-2
|
-10
-23.4%
|
-8
-61.2%
|
-5
+48.1%
|
-10
-331.3%
|
| Basic EPS |
-0.01
-80.0%
|
-0.01
+50.0%
|
-0.01
+28.6%
|
-0.01
-75.0%
|
-0.01
+11.1%
|
-0.01
|
—
|
—
|
—
|
—
|
| Diluted EPS |
-0.01
-80.0%
|
-0.01
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
| Weighted average shares, basic |
312
+2.7%
|
304
+1.3%
|
300
+7.6%
|
279
+3.4%
|
270
|
—
|
—
|
—
|
—
|
—
|
| Weighted average shares, diluted |
312
+2.7%
|
304
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
| Other measures | ||||||||||
| Depreciation and amortization |
0
+22.8%
|
0
-0.6%
|
0
-13.7%
|
0
+5.1%
|
0
+228.3%
|
0
|
0
+15.7%
|
0
-68.4%
|
0
+1692.3%
|
0
+1339.5%
|
| EBITDA |
-4
+9.4%
|
-4
-28.2%
|
-3
+19.0%
|
-4
-86.0%
|
-2
-4.6%
|
-2
|
-5
-14.3%
|
-4
+17.1%
|
-5
+34.7%
|
-8
-254.1%
|
| Margins | ||||||||||
| Gross margin |
—
|
—
|
—
|
—
|
—
|
—
|
100.00%
|
—
|
—
|
—
|
| Operating margin |
—
|
—
|
—
|
—
|
—
|
—
|
-3,658.40%
|
—
|
—
|
—
|
| Profit margin |
—
|
—
|
—
|
—
|
—
|
—
|
-7,640.33%
|
—
|
—
|
—
|
| EBITDA margin |
—
|
—
|
—
|
—
|
—
|
—
|
-3,594.78%
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Industrial Organic Chemicals (SIC 2860)
- Listed as
- BIOF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Palm Beach Gardens, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1549145
- Former names
- ALLIANCE BIOENERGY PLUS, INC. (until Jun 24, 2021); Alliance Media Group Holdings, Inc. (until Nov 19, 2014)
Other Industrial Organic Chemicals companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.